GeraClinic / NHS cancer waiting times / NHS Bristol, North Somerset And South Gloucestershire ICB / Consultant Upgrade
NHS Bristol, North Somerset And South Gloucestershire ICB: Consultant Upgrade — 62-Day Cancer Waits
In April 2026, 83.1% of consultant upgrade cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days — 195 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Consultant Upgrade cancer waiting time in NHS Bristol, North Somerset And South Gloucestershire ICB?
As of April 2026, 83.1% of consultant upgrade cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of referral (162 of 195 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 195 | April 2026 |
| Within 62 days | 162 | Started treatment in time |
| Breaches | 33 | Did not meet 62-day standard |
| 62-day standard met | 83.1% | NHS target: 85% |
| Status vs target | MISSED | Target is 85% |
Other cancer pathways in NHS Bristol, North Somerset And South Gloucestershire ICB
NHS Bristol, North Somerset And South Gloucestershire ICB Consultant Upgrade cancer waits: FAQs
- What is the 62-day cancer waiting time for Consultant Upgrade in NHS Bristol, North Somerset And South Gloucestershire ICB?
- In April 2026, 83.1% of consultant upgrade cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of referral — covering 195 patients (162 within standard, 33 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Consultant Upgrade pathway mean?
- The Consultant Upgrade pathway covers patients who are upgraded onto the 62-day pathway by a clinician — typically because a patient attending for one condition is found to have suspected cancer. The 62-day clock starts from the upgrade decision date.
- How does NHS Bristol, North Somerset And South Gloucestershire ICB's Consultant Upgrade performance compare to England?
- The England average for the 62-day Consultant Upgrade pathway was not separately published at England level in the April 2026 extract. NHS Bristol, North Somerset And South Gloucestershire ICB's 83.1% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS Bristol, North Somerset And South Gloucestershire ICB for the Consultant Upgrade pathway in April 2026, there were 33 breaches out of 195 patients.
Consultant Upgrade cancer waits in NHS Bristol, North Somerset And South Gloucestershire ICB — below NHS target
Only 83.1% of consultant upgrade patients in NHS Bristol, North Somerset And South Gloucestershire ICB met the 62-day standard in April 2026 (target: 85%). GeraClinic can connect you to a UK-registered cancer specialist while you await NHS assessment — your referral is not affected.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.